TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11095346

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b at a dose of 5 million units (MU) daily
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard interferon at a dose of 3 MU three times a week (t.i.w.)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b at a dose of 5 MU daily
Number of subjects: 104
Study: 8936541

Group type: EXPERIMENTAL
Intervention: Tunnelled central venous catheters
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional central venous catheters
Number of subjects: 16
Study: 1468213

Group type: EXPERIMENTAL
Intervention: Spherical contact lens
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Aspherical contact lens
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-contact lens wearing eyes (Control)
Number of subjects: 25
Study: 6148868

Group type: EXPERIMENTAL
Intervention: Nadolol (once daily)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Nadolol plus bendroflumethiazide (both once daily)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Nadolol alone
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Hydralazine (25 to 100 mg twice daily)
Number of subjects: 132
Study: 3549364

Group type: EXPERIMENTAL
Intervention: Sedentary training (ST)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Marathon training (MT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nontraining control (C-NT)
Number of subjects: 21
Study: 31970931

Group type: EXPERIMENTAL
Intervention: Surgical intervention (granuloma excision and AC wash)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conservative treatment (topical prednisolone and cycloplegic drops with orbital floor injection of Triamcinolone acetonide)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 39
Study: 29145166

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a-tDCS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (c-tDCS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study: 25899527

Group type: EXPERIMENTAL
Intervention: Inguinal approach (n = 21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intravesical approach (n = 20)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Inguinal approach
Number of subjects: 41
Study: 25037665

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) for TMD
Number of subjects: 44
Study: 24225475

Group type: EXPERIMENTAL
Intervention: Home-based nursing pulmonary rehabilitation
Number of subjects: 0
Study: 20522533

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.33 mg/kg per week)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nontreatment with GH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 16
Study: 18082502

Group type: EXPERIMENTAL
Intervention: Rescue PCI
Number of subjects: 221

Group type: COMPARATOR
Intervention: Rescue eligible patients
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Emergency angiography before PCI
Number of subjects: 221
Study: 16091920

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH) injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Triamsinolone acetonide injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Physical therapy modalities
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study: 12924620

Group type: EXPERIMENTAL
Intervention: D10S537 marker
Number of subjects: 282
Study: 11122943

Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 10
Study: 8728225

Group type: EXPERIMENTAL
Intervention: Y-set disconnect system (Ultraset)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional spike system
Number of subjects: 40
Study: 2065536

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation radiotherapy
Number of subjects: 172

Group type: COMPARATOR
Intervention: Routine fractionation radiotherapy
Number of subjects: 172
Study: 6671106

Group type: EXPERIMENTAL
Intervention: Temporal artery constriction feedback
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Temporal artery dilation feedback
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 21
Study: 30717815

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for antenatal depression
Number of subjects: 23

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 23
Study: 30176973

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Pain (CBT-P)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 37
Study: 26996051

Group type: EXPERIMENTAL
Intervention: Speech and Gesture
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Speech, Gesture and Face
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Speech, Gesture and Face plus Instruction
Number of subjects: 135

Group type: COMPARATOR
Intervention: Speech Only
Number of subjects: 135
Study: 25034330

Group type: EXPERIMENTAL
Intervention: Oral administration of Cistiquer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intra-vesical administration of betametasone 8 mg plus gentamicin 80 mg
Number of subjects: 60
Study: 21505910

Group type: EXPERIMENTAL
Intervention: Low-dose XLGB (3 g/day, n=61)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: High-dose XLGB (6 g/day, n=58)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (CON group, n=61)
Number of subjects: 180
Study: 20554078

Group type: EXPERIMENTAL
Intervention: Stress cardiac MRI in an observation unit
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard inpatient care
Number of subjects: 110
Study: 18625763

Group type: EXPERIMENTAL
Intervention: Raltegravir at 400 mg twice daily for 4 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) at 300 mg once daily for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Raltegravir at 400 mg twice daily plus TDF at 300 mg once daily for 4 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Raltegravir
Number of subjects: 0
Study: 16143183

Group type: EXPERIMENTAL
Intervention: Cannulated patients
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Decannulated patients
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cannulated and decannulated patients
Number of subjects: 63

Group type: COMPARATOR
Intervention: Noncannulated patients
Number of subjects: 63
Study: 11323536

Group type: EXPERIMENTAL
Intervention: TRT-100 (100 mg oral ketoprofen)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: TRT-25 (25 mg oral ketoprofen)
Number of subjects: 48

Group type: COMPARATOR
Intervention: PLA (exercise + placebo)
Number of subjects: 48
Study: 9389235

Group type: EXPERIMENTAL
Intervention: Stretched technique
Number of subjects: 53

Group type: COMPARATOR
Intervention: Unstretched technique
Number of subjects: 53
Study: 7909525

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal intracellular glutathione levels (20-30 nmol/mg protein)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Suboptimal intracellular glutathione levels (10-20 nmol/mg protein)
Number of subjects: 0
Study: 3209275

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg, verapamil 80 mg, diltiazem 60 mg three times a day (calcium antagonists)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No drug (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (Nifedipine, Verapamil, Diltiazem)
Number of subjects: 40
Study: 30741642

Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC) tool
Number of subjects: 12

Group type: COMPARATOR
Intervention: Paper-Pen Data Capture (PPDC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: System Usability Scale (SUS) score for data collectors using EDC
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of error rates between PPDC and EDC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Qualitative data response mapping for EDC
Number of subjects: 12
Study: 27984524

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Combined therapy (exercise + CBT)
Number of subjects: 884
Study: 25847895

Group type: EXPERIMENTAL
Intervention: SWL with simultaneous inclination (372 patients)
Number of subjects: 740

Group type: COMPARATOR
Intervention: SWL alone (368 patients)
Number of subjects: 740
Study: 22489839

Group type: EXPERIMENTAL
Intervention: Supine-lying position at elbow flexion angle of 45 degrees
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Supine-lying position at elbow flexion angle of 90 degrees
Number of subjects: 22

Group type: COMPARATOR
Intervention: Prone-lying position at elbow flexion angle of 45 degrees
Number of subjects: 22

Group type: COMPARATOR
Intervention: Prone-lying position at elbow flexion angle of 90 degrees
Number of subjects: 22
Study: 21410107

Group type: EXPERIMENTAL
Intervention: AVI with postoperative subconjunctival bevacizumab (SCB) injections (days 1 and 7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: AVI without SCB (control group)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: AVI with SCB
Number of subjects: 13
Study: 19617717

Group type: EXPERIMENTAL
Intervention: New-process PNEUMOVAX II
Number of subjects: 220

Group type: COMPARATOR
Intervention: Former-process PNEUMOVAX II
Number of subjects: 220
Study: 16464492

Group type: COMPARATOR
Intervention: Control group (E) - no composite build-up or post, teeth left empty
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (C) - only resin composite build-up
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: FRC post without ferrule (0/FRC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: FRC post with ferrule (2/FRC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Titanium post without ferrule (0/T)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Titanium post with ferrule (2/T)
Number of subjects: 48
Study: 15013579

Group type: EXPERIMENTAL
Intervention: Internet-based resources for smoking cessation
Number of subjects: 171

Group type: COMPARATOR
Intervention: Standard written self-help materials
Number of subjects: 171
Study: 11673930

Group type: EXPERIMENTAL
Intervention: Specific manipulative therapy treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 9442429

Group type: EXPERIMENTAL
Intervention: Topical application of metronidazole 25% dental gel
Number of subjects: 24

Group type: COMPARATOR
Intervention: Subgingival scaling
Number of subjects: 24
Study: 7946496

Group type: EXPERIMENTAL
Intervention: Hospital at Home (HAH)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (hospital care only)
Number of subjects: 76
Study: 3339790

Group type: EXPERIMENTAL
Intervention: 10 mg of folate plus 500 micrograms of hydroxocobalamin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 28914087

Group type: EXPERIMENTAL
Intervention: Myofascial therapy (12 sessions)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Standard physical therapy program + Myofascial therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo therapy (12 sessions)
Number of subjects: 50
Study: 26958799

Group type: EXPERIMENTAL
Intervention: Angioembolization
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: External fixator placement
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Diagnostic angiography
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Resuscitative endovascular balloon occlusion of the aorta
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Shock group (systolic BP < 90 mm Hg or heart rate > 120 beats/min or base deficit < -5)
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Therapeutic angioembolization in shock group
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: Angiography in shock group
Number of subjects: 1339
Study: 25222089

Group type: EXPERIMENTAL
Intervention: Multiple smaller units (served in Study 1)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Single larger unit (served in Study 1)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Multiple units on separate plates (served in Study 2)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Single unit (served in both studies)
Number of subjects: 129
Study: 23110878

Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nicotine and Varenicline
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Varenicline and Nicotine
Number of subjects: 44
Study: 21612625

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention
Number of subjects: 351

Group type: COMPARATOR
Intervention: Brief intervention
Number of subjects: 351
Study: 19916208

Group type: EXPERIMENTAL
Intervention: Early removal of bladder catheter (removed on the morning after surgery)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard care (bladder catheter removed when epidural analgesia was discontinued, 3-5 days later)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Patients with UTI
Number of subjects: 215
Study: 16686645

Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB) 600 mg/day
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 15220783

Group type: EXPERIMENTAL
Intervention: Classic Labat approach (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lateral popliteal approach (n = 25)
Number of subjects: 50
Study: 11741555

Group type: EXPERIMENTAL
Intervention: High-dose dobutamine stress echocardiography (up to 40 micro/kg/min)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: High-dose dobutamine stress echocardiography
Number of subjects: 186
Study: 7587599

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) treatment, 3 x 10(6) U/day for 14 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not treated with IFN)
Number of subjects: 17
Study: 2794180

Group type: EXPERIMENTAL
Intervention: Television advertisement with letter announcing the campaign
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Television advertisement without letter announcing the campaign
Number of subjects: 96

Group type: COMPARATOR
Intervention: No advertisement with letter announcing the campaign
Number of subjects: 96

Group type: COMPARATOR
Intervention: No advertisement without letter announcing the campaign
Number of subjects: 96
Study: 105697

Group type: EXPERIMENTAL
Intervention: Stannous fluoride toothpaste used twice yearly for three years in supervised brush-ins
Number of subjects: 492

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 492
Study: 31013820

Group type: EXPERIMENTAL
Intervention: Sodium Citrate (CIT) 600 mg·kg‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 20
Study: 28402983

Group type: EXPERIMENTAL
Intervention: Bimonthly intravitreal injections of aflibercept (IVA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Pro re nata (PRN) treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups (PRN and bimonthly)
Number of subjects: 58
Study: 26690036

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Training (WBVT) for 6 weeks, 3 sessions per week, intensity varied from 7.2 g to 32.6 g
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 64
Study: 25181050

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RIPC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 22083471

Group type: EXPERIMENTAL
Intervention: LAMB (3 mg/kg once a day)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: CAS (50 mg QD; day 1, 70 mg)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: CAS-LAMB (combination therapy)
Number of subjects: 53

Group type: COMPARATOR
Intervention: LAMB and CAS
Number of subjects: 53
Study: 21051670

Group type: EXPERIMENTAL
Intervention: STARFlex septal closure system
Number of subjects: 910

Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 910
Study: 17613280

Group type: EXPERIMENTAL
Intervention: Low-fat solid diet (LFSD)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Clear liquid diet (CLD)
Number of subjects: 121
Study: 15769830

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 11932302

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 microg sodium selenite/d, orally, for 3 months)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Selenium supplementation and Placebo
Number of subjects: 70
Study: 9443459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study: 8916260

Group type: EXPERIMENTAL
Intervention: Radiation combined with methylpredonisolone (RT + MP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Radiation alone (RT alone)
Number of subjects: 38
Study: 1865159

Group type: EXPERIMENTAL
Intervention: Intensified conventional treatment (ICT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Regular treatment (RT)
Number of subjects: 96
Study: 6353269

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30611153

Group type: EXPERIMENTAL
Intervention: Bactiseal Universal Shunt (BUS)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Chhabra shunt
Number of subjects: 248
Study: 29168264

Group type: EXPERIMENTAL
Intervention: Miracle fruit seed oil (MFSO) wristband
Number of subjects: 38

Group type: COMPARATOR
Intervention: Vehicle wristband (control)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: MFSO wristband
Number of subjects: 38
Study: 26387118

Group type: EXPERIMENTAL
Intervention: NTU P‐MSF self-assessment
Number of subjects: 120

Group type: COMPARATOR
Intervention: NTU P‐MSF peer assessment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: NTU P‐MSF scores comparison
Number of subjects: 120
Study: 26330893

Group type: EXPERIMENTAL
Intervention: 2-hour turning schedule
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: 3-hour turning schedule
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: 4-hour turning schedule
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: High-risk participants
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Moderate-risk participants
Number of subjects: 942

Group type: COMPARATOR
Intervention: Overall comparison of PrU incidence
Number of subjects: 942
Study: 23853648

Group type: EXPERIMENTAL
Intervention: Face to face education
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Video-based education
Number of subjects: 75
Study: 19922894

Group type: EXPERIMENTAL
Intervention: DPSGC 25 mg under fasted condition
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: DPSGC 25 mg under fed condition
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: DPSGC 50 mg under fasted condition
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: DPSGC 50 mg under fed condition
Number of subjects: 47
Study: 17329276

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 35
Study: 15704705

Group type: EXPERIMENTAL
Intervention: History of domestic violence
Number of subjects: 14100
Study: 11248823

Group type: EXPERIMENTAL
Intervention: 0.02% intraoperative daunorubicin for 3 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water for 3 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 9893219

Group type: EXPERIMENTAL
Intervention: Endurance exercise training (EET), 16 weeks, 3 sessions per week, progressing from 50% to 85% of maximal workload
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CG), no exercise
Number of subjects: 21
Study: 8671137

Group type: EXPERIMENTAL
Intervention: Computer-generated patient-held medical record summary (CHR) plus written personal health record (PHR)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Computer-generated patient-held medical record summary (CHR) only
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Written personal health record (PHR) only
Number of subjects: 364

Group type: COMPARATOR
Intervention: No personal record (Control)
Number of subjects: 364
Study: 2551250

Group type: EXPERIMENTAL
Intervention: (2''R)-4'-0-tetrahydropyranyladriamycin (THP), vincristine (VCR), ACNU
Number of subjects: 60

Group type: COMPARATOR
Intervention: adriamycin (ADM), vincristine (VCR), ACNU
Number of subjects: 60
Study: 1257173

Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Food drink
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inert pill (placebo)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Early drug withdrawal
Number of subjects: 10
Study: 31166038

Group type: EXPERIMENTAL
Intervention: Home-based music intervention (HBMI)
Number of subjects: 60
Study: 27865949

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus (JB-1)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 25995100

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High volume exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 23594787

Group type: COMPARATOR
Intervention: EOC (epirubicin 50 mg/m², oxaliplatin 130 mg/m², capecitabine 1250 mg/m²)
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: mEOC+P (epirubicin 50 mg/m², oxaliplatin 100 mg/m², capecitabine 1000 mg/m², panitumumab 9 mg/kg)
Number of subjects: 553